Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis.


Journal

The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 26 06 2020
accepted: 13 07 2021
pubmed: 26 7 2021
medline: 3 3 2022
entrez: 25 7 2021
Statut: ppublish

Résumé

In the early stages of a pandemic, non-pharmaceutical interventions (NPIs) that encourage physical distancing and reduce contact can decrease and delay disease transmission. Although NPIs have been implemented globally during the COVID-19 pandemic, their intensity and timing have varied widely. This paper analyzed the country-level determinants and effects of NPIs during the early stages of the pandemic (January 1st to April 29th, 2020). We examined countries that had implemented NPIs within 30 or 45 days since first case detection, as well as countries in which 30 or 45 days had passed since first case detection. The health and socioeconomic factors associated with delay in implementation of three NPIs-national school closure, national lockdown, and global travel ban-were analyzed using fractional logit and probit models, and beta regression models. The probability of implementation of national school closure, national lockdown, and strict national lockdown by a country was analyzed using a probit model. The effects of these three interventions on mobility changes were analyzed with propensity score matching methods using Google's social mobility reports. Countries with larger populations and better health preparedness measures had greater delays in implementation. Countries with greater population density, higher income, more democratic political systems, and later arrival of first cases were more likely to implement NPIs within 30 or 45 days of first case detection. Implementation of lockdowns significantly reduced physical mobility. Mobility was further reduced when lockdowns were enforced with curfews or fines, or when they were more strictly defined. National school closures did not significantly change mobility.

Identifiants

pubmed: 34304325
doi: 10.1007/s10198-021-01355-4
pii: 10.1007/s10198-021-01355-4
pmc: PMC8310614
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-117

Informations de copyright

© 2021. The Author(s).

Références

Science. 2020 May 8;368(6491):638-642
pubmed: 32234804
Appl Health Econ Health Policy. 2020 Jun;18(3):329-331
pubmed: 32249361
Int J Public Health. 2020 Apr;65(3):231
pubmed: 32239256
Euro Surveill. 2014 Oct 23;19(42):
pubmed: 25358040
BMJ. 2020 Apr 3;369:m1336
pubmed: 32245802
Swiss J Econ Stat. 2020;156(1):10
pubmed: 32864361
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD006207
pubmed: 21735402
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
PLoS Med. 2006 Jun;3(6):e212
pubmed: 16640458
PLoS Comput Biol. 2011 Feb 10;7(2):e1001076
pubmed: 21347316
Value Health Reg Issues. 2017 Sep;13:67-70
pubmed: 29073992
Sci Bull (Beijing). 2020 Jun 15;65(11):876-878
pubmed: 32296594
Lancet Child Adolesc Health. 2020 May;4(5):397-404
pubmed: 32272089
Lancet. 2020 Apr 4;395(10230):1109-1110
pubmed: 32199470
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet Public Health. 2020 May;5(5):e255
pubmed: 32275857
Cochrane Database Syst Rev. 2020 Sep 15;9:CD013574
pubmed: 33959956
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Plant Physiol. 1995 Feb;107(2):663-4
pubmed: 7724683
Lancet Public Health. 2020 May;5(5):e271-e278
pubmed: 32251626
PLoS Med. 2020 Jul 21;17(7):e1003166
pubmed: 32692736
Lancet Child Adolesc Health. 2020 Jun;4(6):421
pubmed: 32302537
Int J Environ Res Public Health. 2019 Apr 22;16(8):
pubmed: 31013648
Lancet Glob Health. 2020 May;8(5):e644
pubmed: 32222161
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Lancet Public Health. 2020 May;5(5):e243-e244
pubmed: 32275858
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Nature. 2008 Apr 10;452(7188):750-4
pubmed: 18401408
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7582-7
pubmed: 17416679
Lancet Public Health. 2020 May;5(5):e256
pubmed: 32199471
J Health Polit Policy Law. 2012 Dec;37(6):1091-110
pubmed: 22899835
PLoS One. 2021 Mar 4;16(3):e0247461
pubmed: 33661992
BMJ. 2020 Apr 6;369:m1379
pubmed: 32253182
Nat Med. 2021 Feb;27(2):205-211
pubmed: 33469205
Lancet. 2019 Apr 20;393(10181):1628-1640
pubmed: 30878225
Science. 2020 Apr 24;368(6489):395-400
pubmed: 32144116
BMC Public Health. 2018 Apr 18;18(1):518
pubmed: 29669545
PLoS Med. 2007 Jan;4(1):e13
pubmed: 17253899
BMJ. 2020 Apr 7;369:m1395
pubmed: 32265194

Auteurs

Amit Summan (A)

Center for Disease Dynamics, Economics and Policy, 5636 Connecticut Ave NW, PO Box 42735, Washington, DC, 20015, USA. summan@cddep.org.

Arindam Nandi (A)

The Population Council, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH